Related Experiment Video
Updated: Jan 24, 2026

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid
Sarah Sierra Smaga1, Chaoyi Xu2, Brady James Summers1
1Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA.
Abstract:
The human antiviral protein MxB is a restriction factor that fights HIV infection. Previous experiments have demonstrated that MxB targets the HIV capsid, a protein shell that protects the viral genome. To make the conical-shaped capsid, HIV CA proteins are organized into a lattice composed of hexamer and pentamer building blocks, providing many interfaces for host proteins to recognize. Through extensive biochemical and biophysical studies and molecular dynamics simulations, we show that MxB is targeting the HIV capsid by recognizing the region created at the intersection of three CA hexamers. We are further able to map this interaction to a few CA residues, located in a negatively charged well at the interface between the three CA hexamers. This work provides detailed residue-level mapping of the targeted capsid interface and how MxB interacts. This information could inspire the development of capsid-targeting therapies for HIV.
Insights
The human antiviral protein MxB inhibits HIV by targeting its capsid. Researchers mapped MxB
Area of Science:
- Virology
- Structural Biology
- Immunology
Background:
- The human MxB protein acts as a restriction factor against HIV infection.
- MxB targets the HIV capsid, a crucial protein shell protecting the viral genome.
- The HIV capsid is formed by CA proteins assembling into hexamer and pentamer lattices.
Purpose of the Study:
- To elucidate the precise molecular interactions between MxB and the HIV capsid.
- To identify specific residues involved in MxB binding to the capsid structure.
Main Methods:
- Biochemical assays
- Biophysical studies
- Molecular dynamics simulations
Main Results:
- MxB recognizes a specific interface formed by three HIV CA hexamers.
- The interaction site was mapped to a few CA residues within a negatively charged region.
- Detailed residue-level mapping of the MxB-capsid interaction interface was achieved.
Conclusions:
- MxB binds to a unique structural feature at the intersection of three CA hexamers.
- Understanding this interaction provides a basis for designing novel HIV capsid-targeting therapies.
More Related Videos
12:38Structure of HIV-1 Capsid Assemblies by Cryo-electron Microscopy and Iterative Helical Real-space Reconstruction
Published on: August 9, 2011
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Related Concept Videos
Viral Structure
Viral Mutations
Protein-protein Interfaces
Protein-Protein Interfaces
Viral Recombination
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...